Intervention not reported
LDL‐cholesterol fluvastatin 20 mg/day · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐cholesterol fluvastatin 40 mg/day · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐cholesterol fluvastatin 80 mg/day · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
Total cholesterol fluvastatin 10 mg/day · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
Total cholesterol fluvastatin 20 mg/day · participants with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
Total cholesterol fluvastatin 40 mg/day · participants with normal or abnormal lipid profiles
1 finding from 1 review
Day 5 · children with acute otitis media
1 finding from 1 review
Day 14 · children with acute otitis media
1 finding from 1 review
Postoperative delirium (One study used DRS, three studies used CAM and in one study diagnostic tool was not reported) Time points were up to 4 days postoperatively
It is very uncertain whether summary of findings TIVA changes postoperative delirium (One study used DRS, three studies used CAM… compared with inhalational maintenance of anaesthesia (very low certainty).
1 finding from 1 review
Mortality at 30 days
It is very uncertain whether summary of findings TIVA changes mortality At 30 days compared with inhalational maintenance of anaesthesia (very low certainty).
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
Mortality at time point closest to 90 days · participants with internal medicine diseases and conditions
It is very uncertain whether short‐stay unit hospitalisation changes mortality at time point closest to 90 days compared with usual care (very low certainty).
1 finding from 1 review
RR 0.73 [0.47, 1.15]
1294 participants
Very low
Serious adverse events at time point closest to 90 days · participants with internal medicine diseases and conditions
It is very uncertain whether short‐stay unit hospitalisation changes serious adverse events at time point closest to 90 days compared with usual care (very low certainty).
1 finding from 1 review
RR 0.95 [0.59, 1.54]
1907 participants
Very low
Quality of life at time point closest to 90 days · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
1029 participants
Very low
Activities of daily living · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
569 participants
Very low
Patient readmissions · participants with internal medicine diseases and conditions
It is very uncertain whether short‐stay unit hospitalisation changes hospital readmission at time point closest to 90 days compared with usual care (very low certainty).
1 finding from 1 review
RR 0.8 [0.54, 1.19]
1753 participants
Very low
Non‐serious adverse events at time point closest to 90 days · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
533 participants
Very low
Costs · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
1433 participants
Very low
30‐day mortality* · people admitted to intensive care units
It is very uncertain whether automated monitoring systems changes 30‐day mortality* compared with standard care (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Duration of ICU stay · people admitted to intensive care units
1 finding from 1 review